SCHEMBL1737141

SCHEMBL1737141

C=CCn1c(C)c(C)c2cc(C(=O)NCc3ccc(C)cc3)nc(N3CCc4ccccc4C3)c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
TP53 P04637 3/20 0.40
ALDH1A1 P00352 5/20 0.36
MAPT P10636 4/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
LMNA P02545 4/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP2D6 P10635 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ADAMTS4 O75173 2/20 0.36
KDM4E B2RXH2 3/20 0.36
HTT P42858 2/20 0.36
ITGA4 P13612 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1737063 0.99 MAPK1 (0.40) MAPK1L3MBTL1TP53ALDH1A1MAPT
SCHEMBL1739447 0.89 MEN1 (0.42) MAPK1TP53MAPTMEN1KMT2A
SCHEMBL1736750 0.89 ALDH1A1 (0.48) MAPK1L3MBTL1TP53ALDH1A1MAPT
SCHEMBL1736749 0.89 PPARG (0.42) TP53MEN1KMT2ASMN1; SMN2LMNA
Hydrochloric Acid SCHEMBL1738710 0.89 MEN1 (0.42) MAPK1TP53MAPTMEN1KMT2A
SCHEMBL1736729 0.89 GRIN2D (0.41) L3MBTL1TP53ALDH1A1MAPTMEN1
Hydrochloric Acid SCHEMBL1736151 0.88 ALDH1A1 (0.47) MAPK1L3MBTL1TP53ALDH1A1MAPT
Hydrochloric Acid SCHEMBL1737499 0.88 GRIN2D (0.41) L3MBTL1TP53ALDH1A1MAPTMEN1
SCHEMBL1736727 0.88 MAPT (0.39) L3MBTL1ALDH1A1MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL1737059 0.87 MAPT (0.39) L3MBTL1ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784404-B1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2011-11-16 EP claimed
US-20110263306-A1 COMPUTER SYSTEM AND PROGRAM NAMCO BANDAI GAMES INC. (JP) 2011-10-27 US claimed
US-8188114-B2 Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2012-05-29 US disclosed
EP-1784404-B1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2011-11-16 EP disclosed
US-20110263306-A1 COMPUTER SYSTEM AND PROGRAM NAMCO BANDAI GAMES INC. (JP) 2011-10-27 US disclosed
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2010-03-18 US disclosed
US-7662832-B2 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2010-02-16 US disclosed
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H MAPK1 1781/4885L3MBTL1 4876/4885TP53 2941/4885
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H MAPK1 1781/4885L3MBTL1 4876/4885TP53 2941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.